Small cell carcinoma of the prostate with hypercalcemia

International Journal of Urology

Volumn 12, Issue 1, 2005, Pages 108-110

  Hanazawa, Kisaburo ^a   Higashi, Naotaka ^a   Kawachi, Yoshio ^a   Suzuki, Fujihiko ^a   Ishi, Kazuhisa ^a   Fujime, Makoto ^b  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypercalcemia; Prostate; Small cell carcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUTAMIDE; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ABDOMINAL PAIN; AGED; ANTIGEN DETECTION; APPETITE DISORDER; ARTICLE; AUTOPSY; CALCIUM BLOOD LEVEL; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; COMBINATION CHEMOTHERAPY; CONSCIOUSNESS DISORDER; FATIGUE; HUMAN; HYPERCALCEMIA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; PANCREAS METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; SMALL CELL CARCINOMA; SPINE METASTASIS;

AGED; CARCINOMA, SMALL CELL; HUMANS; HYPERCALCEMIA; MALE; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 14744298400     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00977.x     Document Type: Article

References (9)

1. Mackey JR, Au HJ, Hugh J, Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J. Urol. 1998; 159: 1624-9.
2. Smith DC, Tucker JA, Trump DL. Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J. Clin. Oncl. 1992; 10: 499-505.
3. Sella A, Konichezky M, Flex D, Sulkes A, Daniel J. Low PSA metastatic androgen-independent prostate cancer. Eur. Urol. 2000; 38: 250-54.
4. Isshiki S, Akakura K, Komiya A, Suzuki H, Kamiya N, Ito H. Chromogranin A concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer. J. Urol. 2002; 167: 512-15.
5. Cramer SD, Peehl DM, Edgar MG, Wong ST, Deftos LJ, Feldman D. Parathyroid hormone-related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells. Prostate 1996; 29: 20-29.
6. Deftos LJ. Granin-A, parathyroid hormone-related protein, and calcitonin gene products in neuroendocrine prostate cancer. Prostate 1998; 8 (Suppl.): 23-31.
7. Guise TA. Molecular mechanisms of osteolytic bone metastases. Cancer 2000; 88: 2892-8.
8. Kremer R, Goltzman D, Amizuka N, Webber M, Rhim JS. ras Activation of human prostate epithelial cells induces overexpression of parathyroid hormone-related peptide. Clin. Cancer Res. 1997; 3: 855-9.
9. Ming S, Lin S, Logothetis CL. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 2002; 3: 508-513.